Hydreight Technologies Inc. (TSXV:NURS)
Canada · Delayed Price · Currency is CAD 3.970
-0.020 (-0.50%)
At close: Aug 28, 2026
Hydreight Technologies Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 55.78 | 35.39 | 16.04 | 11.51 | 4.27 | 1.2 | |
Revenue Growth | 224.14% | 120.54% | 39.40% | 169.64% | 255.88% | 164.96% |
Cost of Revenue | 43.19 | 26.38 | 10.35 | 6.55 | 2.43 | 0.56 |
Gross Profit | 12.58 | 9 | 5.7 | 4.96 | 1.84 | 0.64 |
Selling, General & Admin | 7.3 | 6.72 | 5.6 | 5.75 | 3.07 | 1.16 |
Other Operating Expenses | 0.33 | 0.35 | -0.25 | 0.59 | - | - |
Operating Expenses | 8.2 | 7.61 | 6.14 | 6.9 | 3.41 | 1.16 |
Operating Income | 4.38 | 1.39 | -0.44 | -1.93 | -1.58 | -0.52 |
Interest Expense | -1.05 | -0.59 | - | - | -0 | - |
Interest & Investment Income | 0.38 | 0.37 | 0.02 | 0.02 | - | - |
Earnings From Equity Investments | 0.03 | 0 | - | - | - | - |
Currency Exchange Gain (Loss) | -0 | -0.01 | 0.02 | -0.02 | 0 | -0 |
Other Non Operating Income (Expenses) | -0.05 | -0.05 | - | - | -0.08 | -0 |
EBT Excluding Unusual Items | 3.68 | 1.11 | -0.41 | -1.94 | -1.66 | -0.52 |
Other Unusual Items | - | - | - | - | -4.34 | - |
Pretax Income | 3.68 | 1.11 | -0.41 | -1.94 | -6 | -0.52 |
Income Tax Expense | -0.58 | -0.58 | - | - | - | 0.01 |
Net Income | 4.26 | 1.69 | -0.41 | -1.94 | -6 | -0.53 |
Net Income to Common | 4.26 | 1.69 | -0.41 | -1.94 | -6 | -0.53 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 48 | 45 | 39 | 38 | 4 | - |
Shares Outstanding (Diluted) | 50 | 47 | 39 | 38 | 4 | - |
Shares Change | 24.44% | 19.71% | 2.86% | 979.30% | - | - |
EPS (Basic) | 0.09 | 0.04 | -0.01 | -0.05 | -1.70 | - |
EPS (Diluted) | 0.09 | 0.04 | -0.01 | -0.05 | -1.70 | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.09 | -1.87 | 0.86 | -0.41 | -0.33 | -0.15 |
Free Cash Flow Per Share | -0.14 | -0.04 | 0.02 | -0.01 | -0.09 | - |
Gross Margin | 22.56% | 25.44% | 35.50% | 43.11% | 43.00% | 53.67% |
Operating Margin | 7.85% | 3.94% | -2.75% | -16.81% | -36.92% | -43.05% |
Profit Margin | 7.64% | 4.79% | -2.53% | -16.83% | -140.45% | -44.01% |
Free Cash Flow Margin | -12.71% | -5.28% | 5.34% | -3.52% | -7.72% | -12.35% |
EBITDA | 4.9 | 1.85 | -0.26 | -1.83 | -1.56 | - |
EBITDA Margin | 8.79% | 5.22% | -1.62% | -15.87% | -36.52% | - |
D&A For EBITDA | 0.53 | 0.45 | 0.18 | 0.11 | 0.02 | - |
EBIT | 4.38 | 1.39 | -0.44 | -1.93 | -1.58 | -0.52 |
EBIT Margin | 7.85% | 3.94% | -2.75% | -16.81% | -36.92% | -43.05% |
Revenue as Reported | 55.78 | 35.39 | 16.04 | 11.51 | 4.27 | 1.2 |